More PYC Therapeutics Limited news
PYC Therapeutics LimitedASX: PYC

Strategic Partnership and Lead Program

Oct 1, 2019 at 12:23 AM EDT · Issued by PYC Therapeutics Limited

Filed with ASX · Oct 1, 2019 at 12:23 AM EDT

On 6ix: 6ix.com/news/strategic-partnership-and-lead-program

Pyc Therapeutics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

PYC Therapeutics Limited on 6ix

Story so far

  • Fourfold Delivery Improvement in a New Lead CandidateOct 29, 2018

Earlier from PYC Therapeutics

  • Successful Time-Course Studies in AnimalsSep 25, 2019
  • Successful Competitive Drug Evaluation in AnimalsSep 2, 2019
  • Response to ASX Aware QueryAug 7, 2019
  • Phylogicas Technology is Effective in Human CellsAug 6, 2019
  • Company Presentation - July 2019Jul 23, 2019

Later from PYC Therapeutics

  • Successful Major Milestone - Human Retina in a Dish ModelsOct 8, 2019
  • Sept 2019 Quarterly Shareholder Update and Appendix 4COct 30, 2019
  • $26.8m Fully Underwritten Accelerated Entitlement OfferOct 30, 2019
  • Entitlement Offer - Investor PresentationOct 31, 2019
  • PYCs Institutional Entitlement Offer ClosesNov 3, 2019
All PYC Therapeutics news releases↗

Follow PYC Therapeutics into a list and get an email when it puts out news.

Follow PYC Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer